PHARMACOKINETICS OF DARUNAVIR IN HCV/HIV COINFECTED ADULTS IN THE PRESENCE AND ABSENCE OF OMBITASVIR, PARITAPREVIR, RITONAVIR, DASABUVIR AND RIBAVIRIN.

被引：0
|
作者：
King, J. R. [1 ]
Eckert, D. [2 ]
Mensing, S. [2 ]
Menon, R. [1 ]
Zha, J. [1 ]
Zha, J. [1 ]
Dutta, S. [1 ]
机构：
[1] AbbVie, N Chicago, NC USA
[2] AbbVie, Ludwigshafen, Germany
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-065
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [1] Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
    Jingjing Wu
    Peng Huang
    Haozhi Fan
    Ting Tian
    Xueshan Xia
    Zuqiang Fu
    Yan Wang
    Xiangyu Ye
    Ming Yue
    Yun Zhang
    Virology Journal, 16
  • [2] Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis
    Wu, Jingjing
    Huang, Peng
    Fan, Haozhi
    Tian, Ting
    Xia, Xueshan
    Fu, Zuqiang
    Wang, Yan
    Ye, Xiangyu
    Yue, Ming
    Zhang, Yun
    VIROLOGY JOURNAL, 2019, 16
  • [3] Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
    Feld, Jordan J.
    Bernstein, David E.
    Younes, Ziad
    Van Vlierberghe, Hans
    Larsen, Lois
    Tatsch, Fernando
    Ferenci, Peter
    LIVER INTERNATIONAL, 2018, 38 (09) : 1571 - 1575
  • [4] Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis
    Pessoa, Mario G.
    Ramalho-Madruga, Jose, V
    Alves, Katia
    Nunes, Estevao P.
    Cheinquer, Hugo
    Brandao-Mello, Carlos E.
    Mendes-Correa, Maria C.
    Ferraz, Maria L.
    Ferreira, Paulo R. A.
    Alvares-da-Silva, Mario R.
    Coelho, Henrique S.
    Affonso-de-Araujo, Evaldo S.
    Furtado, Juvencio
    Parana, Raymundo
    Silva, Giovanni
    Lari, Sara A.
    Liu, Li
    Tripathi, Rakesh
    Pilot-Matias, Tami
    Cohen, Daniel E.
    Shulman, Nancy S.
    Martinelli, Ana
    ANNALS OF HEPATOLOGY, 2018, 17 (06) : 959 - 968
  • [5] Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients
    Sollima, Salvatore
    D'Avolio, Antonio
    Cattaneo, Dario
    Micheli, Valeria
    Milazzo, Laura
    Gervasoni, Cristina
    CLINICAL INFECTIOUS DISEASES, 2016, 63 (02) : 285 - U148
  • [6] PHARMACOKINETICS OF PARITAPREVIR, OMBITASVIR, DASABUVIR, RITONAVIR AND RIBAVIRIN IN SUBJECTS WITH HCV GENOTYPE 1 INFECTION IN PHASE 3 STUDIES
    Mensing, S.
    Sharma, S.
    Eckert, D.
    Polepally, A.
    Khatri, A.
    Podsadecki, T.
    Awni, W.
    Menon, R.
    Dutta, S.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S644 - S644
  • [7] Effectiveness of Ledipasvir/Sofosbuvir±Ribavirin and Ombitasvir/Paritaprevir/Ritonavir plus Dasabuvir±Ribavirin in 996 Genotype 1 HIV/HCV Coinfected Patients Treated in Routine Practice
    Belperio, Pamela S.
    Bhattacharya, Debika
    Shahoumian, Troy A.
    Loomis, Timothy P.
    Goetz, Matthew B.
    Mole, Larry A.
    Backus, Lisa I.
    HEPATOLOGY, 2016, 64 : 957A - 958A
  • [8] COMPARISON OF FREQUENCIES OF DRUG-DRUG INTERACTIONS BETWEEN SOFOSBUVIR/LEDIPASVIR AND OMBITASVIR/DASABUVIR/PARITAPREVIR/RITONAVIR ± RIBAVIRIN AMONG HIV/HCV COINFECTED PATIENTS
    Schriever, C.
    Ahmed, A.
    Delehanty, K. R.
    Yager, J.
    Farrow, G.
    Kashtan, R.
    Lodise, T.
    Patel, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S801 - S801
  • [9] Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection
    Polepally, Akshanth R.
    Badri, Prajakta S.
    Eckert, Doerthe
    Mensing, Sven
    Menon, Rajeev M.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (02) : 333 - 339
  • [10] Effects of Mild and Moderate Renal Impairment on Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir, and Ribavirin Pharmacokinetics in Patients with Chronic HCV Infection
    Akshanth R. Polepally
    Prajakta S. Badri
    Doerthe Eckert
    Sven Mensing
    Rajeev M. Menon
    European Journal of Drug Metabolism and Pharmacokinetics, 2017, 42 : 333 - 339
12345